
Madison International Enters European Life Sciences Sector with Minority Stake in Kadans
Private equity firm Madison International Realty has invested in AXA IM Alts European Life Sciences platform. Madison now owns a minority stake in, and has advisory participation of, Kadans Science Partner, which AXA IM Alts acquired this past December.
The investment is Madison’s first in the European life sciences sector and follows a $200-million commitment made to IQHQ, a U.S. life sciences real estate owner, operator and developer, during 2020. Madison believes the investment will allow Kadans to further progress its strategy for growth in Europe by undertaking new acquisition opportunities and continuing to build out its existing development opportunities.
“Through this investment we have secured a stake in a developer and operator of life sciences real estate in Europe,” said Alex Lukesch, managing director at Madison. “Life sciences is a sector which we are already active in in the U.S. but is still relatively new in Europe and could be poised for further growth.”
Pictured: Rotterdam Science Tower, which Kadans acquired in June.
- ◦Sale/Acquisition